CYX Calyx Ventures Inc

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx") announces the following:

On April 9, 2014, following an evaluation by an Independent Committee of Calyx's
board of directors, it was determined that in Calyx's view, no options for
financing Agrisoma Biosciences Inc. ("Agrisoma") could be found that would be
satisfactory to shareholders of Calyx as Agrisoma had not progressed as
expected. Calyx waived its pre-emptive rights to allow a third party to finance
Agrisoma and on July 2, 2014, Agrisoma completed a financing of $8.0 million
dollars of which $4.8 million was advanced to Agrisoma. The remaining $3.2
million will be advanced pursuant to Agrisoma reaching certain milestones. The
$8.0 million financing has diluted Calyx's interest in Agrisoma from 49.96% to
approximately 25%. In the event Agrisoma requires additional follow-on financing
in the future, further dilution will occur.


In addition, Calyx had a disagreement with Agrisoma over certain terms in the
January 1, 2001 (as amended March 26, 2004) license and sub license agreement
between the two companies. Concurrent with the financing, Calyx and Agrisoma
entered into an agreement which fully and finally settled all matters relating
to the license and sub license agreement with no cash paid nor amounts payable
by either party.


As well, on June 27, 2014 the Canadian Food Inspection Agency gave regulatory
approval for Carinata meal for use in feed for grower and finisher beef cattle
in Canada. The CFIA's approval allows for Carinata meal sales and is an
important part of the continued development for the Resonance Carinata value
chain. CFIA regulatory approval for cattle feed in Canada means that Carinata
meal has satisfied animal safety and efficacy testing.


Calyx is evaluating a number of business opportunities. Among these, Calyx is in
advanced discussions with a group that has filed for an MMPR license. Calyx will
provide further updates as they occur.


About Calyx

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
which is developing early stage agriculture ventures. Calyx brings its depth of
experience, capital and other capacity, including its proprietary intellectual
property to enhance plant yields. In addition to Calyx's shareholding in
Agrisoma Biosciences Inc., a company which is producing a non-food energy
feedstock crop for bioenergy, Calyx is pursuing agri-pharmaceutical and
agri-tech opportunities including MMPR (Marihuana for Medical Purposes
Regulations). For further information about Calyx, please visit
www.calyxbio.com.


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control. 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect.


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
Don Konantz
President & CEO
604-649-5961
dkonantz@calyxbio.com
www.calyxbio.com

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2024 to May 2024

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From May 2023 to May 2024